Skip to nav Skip to content
Join IDSA
Login
Washington, D.C. Oct. 19 - 23

Experience it All, Only at IDWeek 2022

What's New

Vaccines, Variants, and Vigilance

The latest supplement issue published in CID, "Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response Through Partnerships and Collaborations", highlights efforts by CDC and state, local, territorial and tribal partners to improve public knowledge and health during the COVID-19 pandemic.

Hurricane Resources

Hurricane conditions can increase the risk of contagious diseases. Find tips for staying healthy during flooding and resources from CDC, HHS and others on implications for COVID-19, HIV and other clinical care, and more, on our Hurricane Resources page.

IDSA Statement on Global Fund Replenishment

IDSA and HIVMA are pleased that global efforts to end the HIV, tuberculosis and malaria epidemics received much needed investment at the seventh replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

View More

Science Speaks: ID News

Loading...

View All

IDWeek22_RegOpen-IDSA_1560x1000.png

Latest Multimedia

IDSA Media Briefing: Monkeypox Treatment Trials

AMR Congressional Briefing

CDC/IDSA Clinician Call: Updates & Emerging Issues on COVID-19 and Monkeypox

IDSA on Twitter

New in the Journals

View All

Journals

Clinical Infectious DiseasesExternal Link

Clinical Infectious Diseases (CID), one of the most heavily cited journals in the fields of infectio...

Journal of Infectious DiseasesExternal Link

Founded in 1904, The Journal of Infectious Diseases (JID) is the premier global publication for orig...

Open Forum Infectious DiseasesExternal Link

Open Forum Infectious Diseases (OFID) provides a global forum for the publication of clinical, ...

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.